Literature DB >> 24987312

Hepatitis C virus infection and its rheumatologic implications.

Zeynel A Sayiner1, Uzma Haque1, Mohammad U Malik1, Ahmet Gurakar1.   

Abstract

Extrahepatic manifestations are frequently encountered among patients with chronic hepatitis C virus (HCV) infection. Many of these manifestations are autoimmune disorders, with added mortality and morbidity due to involvement of multiple organ systems. Symptoms of HCV infection and rheumatic diseases may be similar and include arthralgia, myalgia, arthritis, and vasculitis. Also, serologic abnormalities may be found in both cases. Some treatment modalities for HCV infection, including interferon therapy, may aggravate the symptoms of rheumatic diseases, thus confounding clinical presentation. It is imperative to distinguish whether symptoms such as arthralgia, myalgia, and arthritis occur in patients with HCV infection due to primary chronic HCV infection or to a newly developed rheumatologic disease process.

Entities:  

Keywords:  Hepatitis C virus; autoimmune disease; rheumatologic implication

Year:  2014        PMID: 24987312      PMCID: PMC4076875     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  101 in total

Review 1.  Large- and small-vessel vasculitis: a critical digest of the 2010-2011 literature.

Authors:  Rosaria Talarico; Chiara Baldini; Alessandra Della Rossa; Chiara Stagnaro; Claudia Ferrari; Nicoletta Luciano; Stefano Bombardieri
Journal:  Clin Exp Rheumatol       Date:  2012-05-11       Impact factor: 4.473

2.  Prevalence of hepatitis C virus antibodies in systemic lupus erythematosus.

Authors:  Pazhanivel Mohan; Muthusubramaniyan Rajasekaran; Porkodi Ramanathan; Jayanthi Venkataraman
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-12       Impact factor: 2.566

Review 3.  Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations.

Authors:  Domenico Sansonno; Franco Dammacco
Journal:  Lancet Infect Dis       Date:  2005-04       Impact factor: 25.071

Review 4.  Hepatitis C virus infection and autoimmunity.

Authors:  R W McMurray; K Elbourne
Journal:  Semin Arthritis Rheum       Date:  1997-02       Impact factor: 5.532

5.  Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward.

Authors:  Ayman El Garf; Bassel El Zorkany; Rasha Gheith; Hala Sheba; Geilan Abdel Moneim; Kamal El Garf
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

6.  The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.

Authors:  E J Kroot; B A de Jong; M A van Leeuwen; H Swinkels; F H van den Hoogen; M van't Hof; L B van de Putte; M H van Rijswijk; W J van Venrooij; P L van Riel
Journal:  Arthritis Rheum       Date:  2000-08

7.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

8.  Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.

Authors:  R Misiani; P Bellavita; D Fenili; G Borelli; D Marchesi; M Massazza; G Vendramin; B Comotti; E Tanzi; G Scudeller
Journal:  Ann Intern Med       Date:  1992-10-01       Impact factor: 25.391

9.  Efficacy and safety of rituximab in type II mixed cryoglobulinemia.

Authors:  Francesco Zaja; Salvatore De Vita; Cesare Mazzaro; Stefania Sacco; Daniela Damiani; Ginevra De Marchi; Angela Michelutti; Michele Baccarani; Renato Fanin; Gianfranco Ferraccioli
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

10.  Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis.

Authors:  A Riccio; L Postiglione; P La Dogana; A Spanò; C Marzocchella; G Tarantino
Journal:  J Biol Regul Homeost Agents       Date:  2008 Jan-Mar       Impact factor: 1.711

View more
  6 in total

Review 1.  Chronic Chikungunya Arthritis and Rheumatoid Arthritis: What They Have in Common.

Authors:  J Kennedy Amaral; Joshua B Bilsborrow; Robert T Schoen
Journal:  Am J Med       Date:  2019-11-06       Impact factor: 4.965

2.  Antiviral treatment prioritization in HCV-infected patients with extrahepatic manifestations - An Egyptian perspective.

Authors:  Hussein El-Fishawy; Gamal Saadi; May Hassaballa; Mohamed Hussein; Wahid Doss; Gaafar Ragab; Rashad Barsoum
Journal:  J Adv Res       Date:  2016-03-02       Impact factor: 10.479

3.  Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection.

Authors:  Alexis Ogdie; Wyki Gina Pang; Kimberly A Forde; Bhangle D Samir; Lakeisha Mulugeta; Kyong-Mi Chang; David E Kaplan; Valerianna K Amorosa; Jay R Kostman; Rajender K Reddy; Ralph H Schumacher; Vincent Lo Re
Journal:  BMC Musculoskelet Disord       Date:  2015-04-19       Impact factor: 2.362

Review 4.  New insights into HCV-related rheumatologic disorders: A review.

Authors:  Patrice Cacoub; Cloé Comarmond
Journal:  J Adv Res       Date:  2016-07-25       Impact factor: 10.479

5.  Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis.

Authors:  Isabela Siloşi; Lidia Boldeanu; Viorel Biciuşcă; Maria Bogdan; Carmen Avramescu; Citto Taisescu; Vlad Padureanu; Mihail Virgil Boldeanu; Anica Dricu; Cristian Adrian Siloşi
Journal:  Int J Mol Sci       Date:  2017-06-19       Impact factor: 5.923

6.  Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese national claims database.

Authors:  Chien-Hsueh Tung; Ning-Sheng Lai; Chung-Yi Li; Shiang-Jiun Tsai; Yen-Chun Chen; Yi-Chun Chen
Journal:  BMJ Open       Date:  2018-07-23       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.